MAP3K14-IN-173

CAS No. 2113617-02-8

MAP3K14-IN-173( MAP3K14 inhibitor )

Catalog No. M13357 CAS No. 2113617-02-8

A novel potent MAP3K14 kinase inhibitor with IC50 of 1.8 nM (NIK autophosphorylation).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1683 Get Quote
50MG 3402 Get Quote
100MG 4680 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MAP3K14-IN-173
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent MAP3K14 kinase inhibitor with IC50 of 1.8 nM (NIK autophosphorylation).
  • Description
    A novel potent MAP3K14 kinase inhibitor with IC50 of 1.8 nM (NIK autophosphorylation); inhibits p-IKKα levels of L363 (NIK translocated multiple myeloma) cells with IC50 of 1.3 nM; exhibits antiproliferative activity on JJN-3 (NIK translocated) multiple myeloma cells (IC50=29 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MAP3K14 inhibitor
  • Pathway
    MAPK/ERK Signaling
  • Target
    MEK
  • Recptor
    MEK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2113617-02-8
  • Formula Weight
    509.614
  • Molecular Formula
    C29H31N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC1=CC(C2=NC(NC3=CC(C#N)=C(CCN4CCOCC4)C=C3C)=NC=C2)=CC5=C1NC[C@@]5(CO)C
  • Chemical Name
    (R)-5-(2-((5-cyano-2-methyl-4-(2-morpholinoethyl)phenyl)amino)pyrimidin-4-yl)-3-(hydroxymethyl)-3-methylindoline-7-carbonitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kargbo RB, et al. ACS Med Chem Lett. 2017 Aug 17;8(9):908-910. 2. Patent WO2017125530 A1, compound example 173.
molnova catalog
related products
  • Refametinib R enanti...

    The R enantiomer of Refametinib, a potent, non–ATP-competitive, highly selective, allosteric inhibitor.

  • NQDI-1

    NQDI-1 is a potent and selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1) with Ki of 500 nM.

  • BIX02189

    BIX02189 is a potent, selective inhibitor of MEK5 catalytic activity with IC50 of 1.5 nM, also inhibits ERK5 catalytic activity (IC50=59 nM).